Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.11 (overall 0.06) | 0.11 |
| cell type Human Protein Atlas | group enriched outside the brain (megakaryocytes) | 0.10 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 1 pathway; mostly mitochondrial quality control | 1.00 |
No case: the score is under the bar. Receipt 4156
Sealed predictions
- FASTKD5 in dopamine neurons, braak+0.39 (p 0.300) → -0.04 (p 0.909)receipt 4163
Swarm cases
receipt 4163: FASTKD5 in dopamine neurons, braak
- power
- full sample +0.24 (p 0.341, n 18), 95% CI -0.26 to +0.63. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.26 (p 0.289, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.33 (p 0.188, n 18). could be the mix.
- skeptic
- leave-one-out range +0.15 to +0.38, sign flips 0; without severely affected donors +0.24 (p 0.341, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FASTKD5 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts